John Fucci
Direktor/Vorstandsmitglied bei SIRPant Immunotherapeutics, Inc.
Profil
John Fucci's current job(s) include being a Partner at BIOS Capital Management LP since 2019 and a Board Member at SIRPant Immunotherapeutics, Inc. since 2021.
His former job(s) include being a Director at Lantern Pharma, Inc. and a Vice President at Steelhead Capital Management LLC from 2016 to 2019.
Mr. Fucci completed his undergraduate degree at Texas Christian University in 2014.
Aktive Positionen von John Fucci
| Unternehmen | Position | Beginn |
|---|---|---|
BIOS Capital Management LP
 BIOS Capital Management LP Investment ManagersFinance BIOS Capital Management LP (BIOS Partners) is a venture capital firm founded in 2014 by Stella Robertson, Aaron Fletcher and Leslie Kreis. The firm is headquartered in Fort Worth, Texas. | Private Equity Investor | 01.05.2014 |
SIRPant Immunotherapeutics, Inc.
 SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology SIRPant Immunotherapeutics, Inc. is a clinical-stage immuno-oncology company based in Hummelstown, PA. The company specializes in developing next-generation macrophage-based immunotherapies for the treatment of hematological malignancies and solid tumors. The cell therapy technology employed by SIRPant is based on the reduction of SIRP? expression combined with activation of the patient's own macrophages. This population of SIRP?low activated macrophages is designed to attack the tumor following injection by activating the patient's immune system to produce broad-spectrum anti-tumor activity that utilizes patient T-cells and antibodies targeting cancer neoantigens. The company was founded by Richard F. Fitzgerald, and the CEO is Robert J. Towarnicki. | Direktor/Vorstandsmitglied | 01.11.2021 |
Ehemalige bekannte Positionen von John Fucci
| Unternehmen | Position | Ende |
|---|---|---|
| LANTERN PHARMA INC. | Direktor/Vorstandsmitglied | 25.11.2019 |
Steelhead Capital Management LLC
 Steelhead Capital Management LLC Investment ManagersFinance Part of BIOS Capital Management LP, Steelhead Capital Management LLC is an alternative investment manager. The company is based in Fort Worth, TX and was founded in 2008. | Private-Equity-Analyst | 02.06.2019 |
Ausbildung von John Fucci
| Texas Christian University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LANTERN PHARMA INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
BIOS Capital Management LP
BIOS Capital Management LP Investment ManagersFinance BIOS Capital Management LP (BIOS Partners) is a venture capital firm founded in 2014 by Stella Robertson, Aaron Fletcher and Leslie Kreis. The firm is headquartered in Fort Worth, Texas. | Finance |
Steelhead Capital Management LLC
Steelhead Capital Management LLC Investment ManagersFinance Part of BIOS Capital Management LP, Steelhead Capital Management LLC is an alternative investment manager. The company is based in Fort Worth, TX and was founded in 2008. | Finance |
SIRPant Immunotherapeutics, Inc.
SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology SIRPant Immunotherapeutics, Inc. is a clinical-stage immuno-oncology company based in Hummelstown, PA. The company specializes in developing next-generation macrophage-based immunotherapies for the treatment of hematological malignancies and solid tumors. The cell therapy technology employed by SIRPant is based on the reduction of SIRP? expression combined with activation of the patient's own macrophages. This population of SIRP?low activated macrophages is designed to attack the tumor following injection by activating the patient's immune system to produce broad-spectrum anti-tumor activity that utilizes patient T-cells and antibodies targeting cancer neoantigens. The company was founded by Richard F. Fitzgerald, and the CEO is Robert J. Towarnicki. | Health Technology |
